These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28043513)

  • 1. Modulation of CD4 and CD8 response to QuantiFERON-TB Plus in patients with active tuberculosis and latent tuberculosis infection followed over time during treatment.
    Chiacchio T; Petruccioli E; Pepponi I; Vanini V; Gualano G; Cirillo D; Palmieri F; Ippolito G; Goletti D
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S141-S142. PubMed ID: 28043513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB Gold Plus kit.
    Petruccioli E; Chiacchio T; Pepponi I; Vanini V; Urso R; Cuzzi G; Barcellini L; Palmieri F; Cirillo DM; Ippolito G; Goletti D
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S25-S26. PubMed ID: 28043588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of interferon-gamma response to QuantiFERON-TB-plus detected by enzyme-linked immunosorbent assay in patients with active and latent tuberculosis infection.
    Petruccioli E; Vanini V; Chiacchio T; Cirillo DM; Palmieri F; Ippolito G; Goletti D
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S143-S144. PubMed ID: 28043514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CD8 T-cell in immune response to tuberculosis-specific antigen in QuantiFERON-TB Gold Plus.
    Tsuyuzaki M; Igari H; Okada N; Suzuki K
    J Infect Chemother; 2020 Jun; 26(6):570-574. PubMed ID: 32067903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus.
    Petruccioli E; Chiacchio T; Pepponi I; Vanini V; Urso R; Cuzzi G; Barcellini L; Cirillo DM; Palmieri F; Ippolito G; Goletti D
    J Infect; 2016 Dec; 73(6):588-597. PubMed ID: 27717779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of specific CD4 and CD8 T-cell responses in QuantiFERON TB Gold-Plus TB1 and TB2 tubes.
    Allen NP; Swarbrick G; Cansler M; Null M; Salim H; Miyamasu M; Howard J; Boyle J; Lewinsohn D; Lewinsohn D
    Tuberculosis (Edinb); 2018 Dec; 113():239-241. PubMed ID: 30514508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
    Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
    Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis.
    Petruccioli E; Vanini V; Chiacchio T; Cuzzi G; Cirillo DM; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2017 Sep; 106():38-43. PubMed ID: 28802403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis.
    Igari H; Ishikawa S; Nakazawa T; Oya Y; Futami H; Tsuyuzaki M; Suzuki K; Matsumura R
    J Infect Chemother; 2018 Feb; 24(2):110-116. PubMed ID: 29054459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Results of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus Assays for Detection of Tuberculosis Infection in Clinical Samples.
    Won D; Park JY; Kim HS; Park Y
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31969422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube tests for patients with active and latent tuberculosis: A prospective cohort study.
    Lee JK; Lee HW; Heo EY; Yim JJ; Kim DK
    J Infect Chemother; 2021 Dec; 27(12):1694-1699. PubMed ID: 34412980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance in active TB of QFT-Plus assay and co-expression of CD25/CD134 in response to new antigens of Mycobacterium tuberculosis.
    Sauzullo I; Mengoni F; Mascia C; Pavone P; Savelloni G; Massetti AP; Lichtner M; Vullo V; Mastroianni CM
    Med Microbiol Immunol; 2019 Apr; 208(2):171-183. PubMed ID: 30623240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.
    Chiacchio T; Delogu G; Vanini V; Cuzzi G; De Maio F; Pinnetti C; Sampaolesi A; Antinori A; Goletti D
    PLoS One; 2017; 12(8):e0183846. PubMed ID: 28837654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients.
    Ryu MR; Park MS; Cho EH; Jung CW; Kim K; Kim SJ; Oh HY; Huh W; Jang HR; Koh WJ; Park HY; Kim YH; Sinn DH; Choi JO; Joh JW; Kim JM; Kim SJ; Park JB; Kang ES
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30135226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of QuantiFERON-TB Gold Plus Test for Diagnosis of Mycobacterium tuberculosis Infection in Children.
    Buonsenso D; Delogu G; Perricone C; Grossi R; Careddu A; De Maio F; Palucci I; Sanguinetti M; Valentini P; Sali M
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32229602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study.
    Pérez-Recio S; Pallarès N; Grijota-Camino MD; Sánchez-Montalvá A; Barcia L; Campos-Gutiérrez S; Pomar V; Rabuñal-Rey R; Balcells ME; Gazel D; Montiel N; Vicente D; Goić-Barišić I; Schön T; Paues J; Mareković I; Cacho-Calvo J; Barac A; Goletti D; García-Gasalla M; Barcala JM; Tórtola MT; Anibarro L; Suárez-Toste I; Moga E; Gude-Gonzalez MJ; Naves R; Karslıgil T; Martin-Peñaranda T; Stevanovic G; Trigo M; Rubio V; Karaoğlan İ; Bayram N; Alcaide F; Tebé C; Santin M;
    Microbiol Spectr; 2021 Dec; 9(3):e0097221. PubMed ID: 34756079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positivity rate of interferon-γ release assays for estimating the prevalence of latent tuberculosis infection in renal transplant recipients in Japan.
    Igari H; Akutsu N; Ishikawa S; Aoyama H; Otsuki K; Hasegawa M; Maruyama M; Tsuyuzaki M; Suzuki K; Saigo K
    J Infect Chemother; 2019 Jul; 25(7):537-542. PubMed ID: 30905632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection.
    Petrone L; Vanini V; Chiacchio T; Petruccioli E; Cuzzi G; Schininà V; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2018 Jul; 111():147-153. PubMed ID: 30029901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold in-tube for diagnosis of latent tuberculosis infection among highly TB exposed gold miners in South Africa.
    Ntshiqa T; Chihota V; Mansukhani R; Nhlangulela L; Velen K; Charalambous S; Maenetje P; Hawn TR; Wallis R; Grant AD; Fielding K; Churchyard G
    Gates Open Res; 2021; 5():66. PubMed ID: 37560544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.